neurotechnology

(redirected from Neurotech)

neurotechnology

[‚nu̇·rō·tek′näl·ə·jē]
(engineering)
The application of microfabricated devices to achieve direct contact with the electrically active cells of the nervous system (neurons).

neurotechnology

The examination of the human brain using MRI, CAT scan, EEG and other scanning technologies. "Neuropharmacology" uses neurotechnology to study the effects of how drugs, nutrients and food change the brain's behavior. See neuroinformatics.
Mentioned in ?
References in periodicals archive ?
The first cohort of participants recently presented at the Neurotech Investing and Partnering Conference on April 8 at the Hotel Nikko in San Francisco to an audience of 150 neuroscience professionals.
Publisher Neurotech Press revealed on Wednesday that it has published a new health and medicine title by Jennifer French and James Cavuoto, which profiles people who have been among the first to use new or experimental therapies or devices.
Disclosures: The study was funded by Cervel Neurotech, the company developing the new device.
Neurotech reported that, over a 12-month period, 96.
Topics covered include biotech, nanotech, neurotech, information technology, weapons, energy and fuel, space-based technology, and new media and communications.
As one of the first indexes focusing on a specific disease category, the Nasdaq NeuroInsights Neurotech Index (created in conjunction with NeuroInsights) includes 32 companies from the drug, device and diagnostic sectors, which have combined market value of $71 billion.
Link, PhD, of Versant Ventures; and Lutz Giebel, PhD, of SV Life Sciences will join the Neurotech Board of Directors, along with Laurent Ganem, MD, of Apax Partners, and Ted Danse, president and CEO.
ICC Venture Capital has completed a EUR13m investment in Bio-Medical Research, the owner of the Slendertone and Neurotech brands.
On the first day of each month, Neurotech Insights is delivered to your inbox giving you competitive intelligence on the neurotechnology industry.
Chronic neuropathic pain affects millions of individuals worldwide leading to a marked reduction in health and a significant increase in global economic burden, said Bret Schneider, MD, founder and chief medical officer of Cervel Neurotech, Inc.